It is important to determine which GPCRs are overexpressed and what downstream signaling mechanisms are involved during carcinogenesis as a growing body of evidence connects abnormal GPCR expression and activation to a variety of cancers in humans. The gene discussed is LPAR3; the disease is cancer.